Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Astellas Pharma Europe Ltd - Navigating the evolving landscape of locally advanced unresectable or metastatic G/GEJ adenocarcinoma

The current landscape for locally advanced unresectable or metastatic G/GEJ adenocarcinoma

Date

12 Sep 2022

Session

Astellas Pharma Europe Ltd - Navigating the evolving landscape of locally advanced unresectable or metastatic G/GEJ adenocarcinoma

Topics

Tumour Site

Gastric Cancer;  Gastro-Oesophageal Junction Cancer

Presenters

Hanneke van Laarhoven

Authors

H.W.M. van Laarhoven

Author affiliations

  • Medical Oncology Dept., Academic Medical Center, University of Amsterdam, 1100 DD - Amsterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.